This is the first report which analyzed the clinical and genetic features of AR-CMT2S in the mainland of China. We found the frequency of IGHMBP2 mutations is 6.5% in CMT2 without dominant inheritance. We analyzed the effect of the novel splice acceptor site mutation c.1061-2A > G at RNA level of IGHMBP2.